IOP


Also found in: Dictionary, Thesaurus, Medical, Encyclopedia, Wikipedia.
AcronymDefinition
IOPIntensive Out Patient (treatment program)
IOPInstitute Of Physics
IOPIntraocular Pressure
IOPInstitute of Psychiatry
IOPIntensive Outpatient Program
IOPIntensive Outpatient Program (psychotherapy)
IOPInteroperability
IOPIn Original Packaging
IOPInstitute of Politics (Harvard University)
IOPIsle of Palms (South Carolina)
IOPIndirect Object Pronoun (education)
IOPIncreased Intraocular Pressure
IOPInput Output Port
IOPInput Output Platform
IOPInteroperability Provider
IOPInput Output Processor
IOPInstitute of Packaging (UK)
IOPInstitute of Oriental Philosophy (Japan)
IOPInternational Outreach Program (various locations)
IOPInstitute of Plumbing
IOPInternational Online Pharmacy
IOPIn-Orbit Plane (US NASA)
IOPInternational Opportunities Program
IOPInternational Organisation of Palaeobotany
IOPInternal Operating Procedure
IOPInternal Occipital Protuberance (anatomy)
IOPInstitute of Philosophy
IOPIntensive Operational Period
IOPInternational Organization of Psychophysiology (UN)
IOPInput/Output Package
IOPInstitute of Paper
IOPInherent Optical Property
IOPInnocent Owner/Operator Program
IOPIntensive Operating Period
IOPInternal Oral Presentation (examination)
IOPInstitutional Operating Plan
IOPIntelligent Operator Panel (Siemens)
IOPIntense Observation Period
IOPInstrument of Power
IOPIncreased Offertory Program (church offerings; various locations)
IOPIndividual Oral Presentation (International Baccalaureate assignment)
IOPInput/Output Parameter
IOPInterim Operating Procedure
IOPInanimate Objects Party
IOPInfrastructure Optimization Project
IOPInterface Operating Procedure
IOPInstallation Operating Program
IOPInformational One-Pager
IOPInternal Operating Profit
IOPItem of Priority
IOPIntensive Observation/Observing Period
IOPIndividual Owner's Plan (surveying; Canada)
IOPInformation Operations Platform (US Air Force)
IOPIntegrated Office Package
IOPInstrument Operating Procedure
References in periodicals archive ?
Aerie's second product for the reduction of elevated IOP in patients with open-angle glaucoma or ocular hypertension, Rocklatan (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005%, the first and only fixed-dose combination of Rhopressa and the widely-prescribed PGA (prostaglandin analog) latanoprost, has been approved by the FDA and was launched in the United States in the second quarter of 2019.
The results of the Tukey post hoc test showed that before intervention, the mean of IOP in the local anaesthetic group was significantly higher than the laryngeal mask group (p= 0.003), the McCoy group (p= 0.006) and the video GlideScope group (p = 0.002).
Twelve pigeons (20 eyes) that were euthanatized for other research purposes were used immediately after euthanasia for manometric calibration, and 24 clinically normal pigeons (48 eyes) were surveyed to establish normal reference values of IOP. Healthy adult pigeons of undetermined sex were used in this study.
Subjects were seated for 10 minutes, after which 6 serial IOP measurements were taken in quick succession from their right eye with the Icare PRO tonometer while they remained in sitting position.
Normal IOP in healthy young adults ranges from 10 to 21 mmHg.
A number of studies1-5 have reported that, individuals with diabetes mellitus (DM) experience a high prevalence of increased intraocular pressure (IOP) and primary open-angle glaucoma (POAG).
08 Which other IOP lowering agent is combined with the drug shown to form Cosopt?
Various authors have concluded that a significant relation exist between high IOP and diabetes, however the underlying etiology is not clear6,7.
The Wilcoxon test was used to compare the postoperative IOP and number of glaucoma medications with the baselines.
IOP was measured using a Tono-pen[R] XL by a trained ophthalmologist who was unaware of the perioperative fluid administration regimen.
Prostaglandin analogs (PGAs) are FPreceptor agonists that reduce IOP by increasing aqueous humor outflow via remodeling of the ciliary muscle extracellular matrix, subsequently increasing uveoscleral outflow (SMITH et al., 2010).
IOP held a single close on June 30, 2017, achieving its hard cap for Fund III after a three-month fundraising process, and exceeding Fund III's original target of USD 400 million.